Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community Access to Rectal Artesunate for Malaria (CARAMAL): Observational Research in Nigeria, Uganda and DR Congo

NCT03568344 is registered in ClinicalTrials.gov with Swiss Tropical & Public Health Institute as lead sponsor.

NCT NCT03568344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03568344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community Access to Rectal Artesunate for Malaria (CARAMAL): Observational Research in Nigeria, Uganda and DR Congo
Lead sponsor
Swiss Tropical & Public Health Institute
Phase
Observational
Overall status
Completed
Start date
June 15, 2018
Completion date
August 31, 2021
Enrollment
13,758 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malaria